The Howard University MSI HIV/HCV Prevention Program (MSI-H2P)
Wilbert C. Jordan, M.D., M.P.H., is the medical director of the OASIS Clinic of King/Drew Medical Center. Dr Jordan has committed himself to HIV/AIDS research and prevention since the early 1980s. He has been involved with the AIDS epidemic from its recognition and in 1983 reported the first heterosexual case of HIV in Los Angeles County. Dr. Jordan was part of the NIH/FDA/National Medical Association Committee that formulated the design of the NIH sponsored DATRI Study on low dose oral alpha interferon. He has served on the Los Angeles County HIV Planning Council and the Prevention and Planning Committee since their inceptions. Dr. Jordan has also been the medical director for the Minority AIDS Project since its creation and chaired the Black Los Angeles AIDS Consortium for the past 12 years. He has been on the board of directors of the AIDS Research Alliance for several years. His areas of research have included the following: genotyping to confirm drug resistance to anti-retroviral therapy; comparing the anti-retroviral activity and tolerability of different treatment regimens; and, focused interventions for identifying new HIV-positive clients through active patients.